Loss of the Mecp2 gene in parvalbumin interneurons leads to an inhibitory deficit in the amygdala and affects its functional connectivity.
Maj Liiwand, Joni Haikonen, Bojana Kokinovic and 4 others
PMID 41491494WHAT IT FOUND
In mice, losing the Rett syndrome gene in specific brain cells weakened inhibition in the amygdala.
This caused the amygdala to become overactive and disconnected from regions handling fear and social behavior. The deficit appeared in late adolescence.
Key findings
01Loss of the Mecp2 gene in parvalbumin interneurons reduced the release of GABA, weakening both fast and slow inhibitory signals to principal neurons in the lateral amygdala.
02This inhibitory deficit led to increased excitability in amygdala principal neurons and reduced functional connectivity between the amygdala, ventral hippocampus, and medial prefrontal cortex.
03The inhibitory deficit emerged during the third postnatal week in mice, a period corresponding to late adolescence, before significantly affecting neuronal excitability.
STILL TO COME
How it was doneWhat they found
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
The study was conducted entirely in mice, so the findings do not directly apply to human patients. Only male mice were used, whereas Rett syndrome primarily affects girls. The gene deletion was not complete; about 30% of PV interneurons in adults and 62% in adolescents still expressed the MeCP2 protein. The knockout affected PV interneurons in multiple brain regions, so it is unclear which specific population caused the connectivity changes.
Declared interests
The work was funded by the University of Helsinki. No other conflicts of interest were reported.
The easy way to misread this
Do not interpret these findings as evidence of a mechanism for human speech, language, or occupational therapy interventions. This is a basic science study in mice that describes a cellular defect in the amygdala, a brain region involved in fear and social processing, but it does not test any therapy or measure any clinical outcome relevant to human rehabilitation.
Summarised by AI from the full paper, without a clinician reviewing it. Check it against the source before it changes what you do. Read it on PubMed →